Newbridge Financial Services Group, Inc. Catalent, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$109.17 - $142.35 $3,930 - $5,124	-36 Reduced 61.02%	23 $3,000
Q2 2021 Sep 07, 2021	SELL	$100.34 - $115.69 $2,408 - $2,776	-24 Reduced 28.92%	59 $6,000
Q1 2021 Sep 07, 2021	BUY	$101.51 - $125.27 $2,334 - $2,881	23 Added 38.33%	83 $9,000
Q3 2020 Sep 07, 2021	BUY	$72.74 - $92.5 $4,364 - $5,550	60 New	60 $5,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.